Irvine eyecare company sold for $500 million

Irvine eyecare company sold for $500 million

Irvine : CA : USA | Mar 26, 2012 at 9:51 PM PDT
Source: The Orange County Register
Views: Pending
Pharmaceuticals said late Monday that it had a deal to be acquired by global eyecare giant Bausch+Lomb for roughly $500 million. U.S. products, our companies have known each other well for many years. We share a strong overlapping customer base in the U.S., a commitment to serving our physicians and... FULL ARTICLE AT The Orange County Register
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
  • Credibility
  • Wait... Flag

News Stories

  • Xamthone plus

    Submitted By: pananjung19 | over 2 years ago
    Xamthone Plus JUS KULIT MANGGIS | JUS MANGGIS XAMTHONE | XAMTHONE PLUS xamthone plus Mempunyai masalah tentang keluhan penyakit yang anda alami ? kami disini akan mempersembahkan informasi tentang pengobatan yang luar biasa ajib dan aman serta tanpa ...
  • Bausch + Lomb to purchase ISTA

      Pharmaceutical Industry News
    Pharmaceuticals for $9.10 per share in cash, or a total of approximately $500m...The companies will continue to operate independently until completion of the transaction. Goldman, Sachs & Co served as financial advisor to Bausch + Lomb in the...

More From Allvoices

Most Commented Reports

Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.